DesignMedix

📍 Portland, United States🗓 Founded 2008👥 7 employees💰 Last funded Apr 2017
Pharmaceuticals🌐 designmedix.com
Website LinkedIn
DesignMedix develops impactful disease cures that overcome drug resistance. The Company has an innovative approach that takes advantage of existing drugs used safely and effectively for years before resistance arose. Modifying those drugs with strategic designs to overcome drug resistance results in cost-effective, novel drugs. The initial project, a cure for drug-resistant malaria, works on all human malaria samples tested, no matter how resistant to other drugs. The drug is being formulated for Phase I human trials, sponsored by the National Institutes of Health, National Institute of Allergy and Infectious Disease. The DesignMedix product pipeline includes additional discovery stage novel, antimicrobial treatments.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in DesignMedix?
DesignMedix has 1 investors on record on gritt.io and 1 late-stage investors.
When did DesignMedix last raise funding?
The most recent investment in DesignMedix recorded on gritt.io was in April 2017.
When was DesignMedix founded?
DesignMedix was founded in 2008.
What industry is DesignMedix in?
DesignMedix operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is DesignMedix based?
DesignMedix is headquartered in Portland, United States.